Browsing by Author "Vernon, John"
Now showing items 1-9 of 9
-
A Computer Simulation Model of Pharmaceutical Innovation
Grabowski, HG; Vernon, John (Pharmaceutical Economics, 1984) -
A Computer Simulation Model of Pharmaceutical Innovation
Grabowski, HG; Vernon, John (Pharmaceutical Economics: Papers Presented at the 6. Arne Ryde Symposium, Helsingborg, Sweden 1982, 1984) -
A New Look at the Returns and Risks to Pharmaceutical R & D
Grabowski, Henry G; Vernon, John (Management Science, 1990-07) -
Impact of Public Policy on Drug Innovation and Pricing
Grabowski, HG; Vernon, John; Thomas, Lacy Glenn (Impact of Public Policy on Drug Innovation and Pricing, 1976) -
Longer Patents for Lower Imitation Barriers: The 1984 Drug Act
Vernon, John (The American Economic Review, 1986-05) -
Pressures from the Demand Side: Changing Market Dynamics and Industrial Structure
Grabowski, HG; Vernon, John (Consolidation and Competition in the Pharmaceutical Industry, 2001) -
R&d Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
DiMasi, Joseph A; Vernon, John; Grabowski, Henry (International Journal of the Economics of Business, 1995-01-01)This study examines the relationships between firm size, R&D costs and output in the pharmaceutical industry. Project-level data from a survey of 12 US-owned pharmaceutical firms on drug development costs, development phase ... -
Returns on R&D for 1990s New Drug Introductions
Grabowski, Henry; Vernon, John; DiMasi, Joe (PharmacoEconomics, 2002) -
The Pharmaceutical Industry
Grabowski, HG; Vernon, John (1982)FISHER and TEMIN (1973) have argued recently that many empirical studies1 relating to the Schumpeterian hypothesis are inappropriate for testing that hypothesis. They observe that Schumpeter can be interpreted as hypothesizing ...